Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain Fox Business Merck says its Covid antiviral treatment less effective than first thought Financial Times Pfizer/BioNTech seeking data on new COVID variant Reuters Omicron COVID-19 variant: Moderna announces strategy for addressing new variant Fox Business
https://bit.ly/3FT0DE4
No comments:
Post a Comment